Wednesday, October 23

Health

Teva to pay 5M to settle ldl cholesterol drug price-fixing prices
Health

Teva to pay $225M to settle ldl cholesterol drug price-fixing prices

The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing prices associated to gross sales of a serious cholesterol-lowering drug. The U.S. Department of Justice mentioned the settlement additionally requires Teva to divest its enterprise making and promoting the drug, pravastatin, a generic model of the brand-name medication Pravachol. ...